| Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations M Alshamrani, A AlHarbi, N Alkhudair, F AlNajjar, M Khan, AB Obaid, ... Journal of oncology pharmacy practice 26 (6), 1429-1440, 2020 | 30 | 2020 |
| Apalutamide: emerging therapy for non-metastatic castration-resistant prostate cancer NA Alkhudair Saudi Pharmaceutical Journal 27 (3), 368-372, 2019 | 14 | 2019 |
| KRAS mutations in colorectal cancer: relationship with clinicopathological characteristics and impact on clinical outcomes in Saudi Arabia M Alghamdi, N Alabdullatif, A Al-Rashoud, J Alotaibi, N Alhussaini, ... Cureus 14 (3), 2022 | 12 | 2022 |
| Evaluation of eltrombopag in thrombocytopenia post Hematopoietic cell transplantation: Rertrospective observational trial H Samarkandi, M Al Nahedh, A Alfattani, F Alsharif, N Bakshi, W Rasheed, ... Hematology/Oncology and Stem Cell Therapy, 2020 | 12 | 2020 |
| Cancer management in Saudi Arabia: recommendations by the Saudi oncology HeAlth economics ExpeRt GrouP (SHARP) N Alkhudair, M Alshamrani, H Samarkandi, H Almodaheem, ... Saudi Pharmaceutical Journal 29 (2), 115-120, 2021 | 8 | 2021 |
| Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview AK Alshememry, NB Alsaleh, N Alkhudair, R Alzhrani, A Alshamsan Frontiers in Pharmacology 13, 933457, 2022 | 7 | 2022 |
| Bortezomib for immune thrombocytopenia and autoimmune hemolytic anemia IN Muhsen, A Alahmari, M Alnahedh, NA Alkhudair, H Samarkandi, ... Hematol Oncol Stem Cell Ther 13 (4), 251-4, 2020 | 6 | 2020 |
| Association between obesity and COVID-19 disease severity in Saudi Population FY Alqahtani, FS Aleanizy, RAEH Mohamed, N Al-Maflehi, BM Alrfaei, ... Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 1527-1535, 2022 | 5 | 2022 |
| Assessing the impact of chemotherapy-induced nausea and vomiting on patients’ quality of life: an Arabic version of the Functional Living Index-Emesis AM Alhammad, N Alkhudair, R Alzaidi, LS Almosabhi, MH Aljawadi Journal of Oncology Pharmacy Practice 28 (3), 535-541, 2022 | 4 | 2022 |
| Academic entitlement among pharmacy students in the arab world: a multi-national exploratory study DH Halat, AA Al-Jumaili, KK Ahmed, M Rahal, A Hamad, RM Darwish, ... American Journal of Pharmaceutical Education 88 (2), 100640, 2024 | 2 | 2024 |
| Comparison of medical documentation between pharmacist-led anticoagulation clinics and physician-led anticoagulation clinics: A retrospective study M Almuqbil, H Alturki, L Al Juffali, N Al-Otaibi, N Awaad, N Alkhudair, ... Saudi Pharmaceutical Journal 31 (11), 101795, 2023 | 2 | 2023 |
| Implementing oncology pharmacy boot camp for advanced pharmacy practice experience students at a Regional conference in Saudi Arabia M Alnuhait, A Alharbi, A Alanizi, N Alkhudair, M Alshamrani, E Bajnaid, ... Cureus 15 (2), 2023 | 1 | 2023 |
| Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: an international survey of oncology pharmacy practitioners G Chazan, J Jupp, T Bauters, N Duncan, KJ Weddle, H Nomura, ... Journal of Oncology Pharmacy Practice 28 (8), 1832-1847, 2022 | 1 | 2022 |
| Translation, Cross-Cultural Adaptation, and Psychometric Properties of the Revised Fibromyalgia Impact Questionnaire (FIQR) for Use in Arabic-Speaking Patients in Saudi Arabia SS Alaujan, HM Almalag, SH Almazrou, NA Alkhudair, FA Alodaibi, ... Patient preference and adherence, 1017-1025, 2024 | | 2024 |
| Discontinuation of tyrosine kinase inhibitor therapy and treatment free remission (TFR) in chronic myeloid leukemia: Successful achievement of TFR in more than two-third of … A Aleem, NA Shaheen, F Algahtani, A Jamal, N Alkhudair, M Alghafis, ... Clinical Lymphoma Myeloma and Leukemia, 2024 | | 2024 |
| Correction: Comparative Assessment of Drug Lag for Approved Oncology Targeted Therapies Between Saudi Arabia, the United States, and the European Union M Alnuhait, A Alshammari, M Alharbi, L Alotaibi, R Alharbi, A Khobrani, ... Therapeutic Innovation & Regulatory Science 58 (4), 687-688, 2024 | | 2024 |
| Comparative Assessment of Drug Lag for Approved Oncology Targeted Therapies Between Saudi Arabia, the United States, and the European Union M Alnuhait, A Alshammari, M Alharbi, L AlOtaibi, R Alharbi, A Khobrani, ... Therapeutic Innovation & Regulatory Science 58 (4), 678-686, 2024 | | 2024 |
| Clinical Characteristics and Outcomes of Patients Newly Diagnosed with Hodgkin Lymphoma: A Multicenter Descriptive Cohort Study Hodgkin Lymphoma features and outcomes in Saudi … M Alalawi, AM Alrajhi, WA Alshahrani, AH Alotaibi, AA Issa, A Abumostafa, ... | | 2024 |
| Understanding the Quality of Life Among Patients With Cancer in Saudi Arabia: Insights From a Cross-Sectional Study MH Aljawadi, N Alkhudair, M Alrasheed, AS Alsuhaibani, BJ Alotaibi, ... Cancer Control 31, 10732748241263013, 2024 | | 2024 |
| Ambulatory care hematology/oncology pharmacy services: A comprehensive review by the Saudi Oncology Pharmacy Assembly N Alsuhebany, N Alkhudair, M Alzahrani, F Alnajjar, AM Alrajhi, ... Journal of the American College of Clinical Pharmacy 7 (6), 570-580, 2024 | | 2024 |
